| Financial Year |
March 31 2023 |
| Monetary Funds |
305,045,252.57 |
| Held-for-trading Financial Assets |
30,597,065.62 |
| Notes Receivable |
-- |
| Accounts Receivable |
77,070,206.17 |
| Advances to Suppliers |
23,971,483.76 |
| Other Receivables |
122,959,437.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,620,000.00 |
| Inventories |
177,640,644.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,004,891.94 |
| Total Current Assets |
845,340,462.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,885,543.53 |
| Investment Properties |
486,187,620.94 |
| Fixed Assetes |
1,244,216,327.00 |
| Under-construction Projects |
32,554,822.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
231,885,920.57 |
| R&D expenses |
-- |
| Goodwill |
615,303,083.00 |
| Long-Term Deferred and Prepaid Expenses |
8,706,115.43 |
| Deferred Income Tax Assets |
39,168,503.16 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,888,291,324.32 |
| Total Assets |
3,733,631,786.88 |
| Short-Term Loans |
37,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,500,000.00 |
| Accounts Payable |
234,577,825.58 |
| Accounts Received In Advance |
4,423,068.73 |
| Employee Compensation Payable |
30,899,526.42 |
| Taxes Payable |
5,811,753.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,242,949.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
244,692,416.75 |
| Other Current Liabilities |
1,746,693.09 |
| Sub-Total of Current Liabilities |
802,018,665.26 |
| Long-term Loans |
904,183,472.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,627,854,171.77 |
| Deferred Income Tax Liabilities |
25,260,267.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,720,373,510.20 |
| Total Liabilities |
3,522,392,175.46 |
| Paid-In Capital(Or Share Stock) |
762,979,719.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-970,566,638.46 |
| Minority Stockholder's Interest |
393,688,486.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-182,448,874.74 |
| Owner's Equity（Stockholder's Equity） |
211,239,611.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,733,631,786.88 |
